Xinming Su

Supplementary Table S1 from p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

Douglas V. Faget, Xianmin Luo, Matthew J. Inkman, Qihao Ren et autres

Table containing all of our reagents

Supplementary Figures S1-S10 from p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy

Douglas V. Faget, Xianmin Luo, Matthew J. Inkman, Qihao Ren et autres

Contains supplemental figures and legends

Progress in the integration of 3D printing technology with photothermal materials for osteosarcoma treatment

Yue Zheng, Zhen Gao, Ling Zhu, Yiwei Zhang et autres

Osteosarcoma, a highly aggressive primary bone malignancy, presents poor prognosis in metastatic or recurrent cases, driving demand for innovative therapies. Photothermal therapy (PTT) emerges as a promising tumor ablation method due to its minimally invasive, selective nature. Combined with three-dimensional (3D)-printed scaffolds, …

cn (code pays fourni par la source)

Invisible medical records and mRNA delivery via microneedles: A leap toward equitable healthcare

Yue Hong Zheng, Ling Zhu, Xinming Su, Junjie Niu et autres

cn (code pays fourni par la source)

Liquid biopsy based on EV biomarkers: A new frontier for early diagnosis and prognosis assessment of cancer at ESMO 2024

Zeping Shan, Xinming Su, Luqing Liu, Shiwei Duan

Extracellular vesicles (EVs) are emerging as powerful biomarkers in liquid biopsy, offering insights into early cancer diagnosis, precision treatment, and prognosis evaluation. EVs, including microvesicles, exosomes, and apoptotic bodies, carry molecular cargo that reflects the physiological or pathological state of parent cells. …

cn (code pays fourni par la source)

Abstract 1212: Disruption of Gαs/cAMP-mediated acid sensing by breast tumor cells blunts tumor-induced immune suppression and decreases bone metastases by enhancing cytotoxic T cell function

Kaylee M. O'Donnell, Xinming Su, Netra Navadkar, Yalin Xu et autres

Abstract Patients with bone metastases treated with immune checkpoint blockade (ICB) often have decreased response rates compared to patients with visceral metastases only. Increased proton extrusion by tumor cells due to the Warburg effect is associated with tumor progression, metastasis, reduced efficacy …

us (code pays fourni par la source)

Adjuvant immunotherapy improves survival in completely resected stage IB–III NSCLC: a systematic review and meta-analysis

Hong Huang, Pengchen Bao, Hongyu Jin, Wenyang Li et autres

Background The clinical benefits of postoperative chemotherapy for non-small cell lung cancer (NSCLC) have plateaued, thus highlighting the need for novel strategies. This meta-analysis evaluated the efficacy and safety of adjuvant immunotherapy in patients with completely resected NSCLC and wild-type epidermal growth …

cn (code pays fourni par la source)

miR-660: A novel regulator in human cancer pathogenesis and therapeutic implications

Zehua Wang, Xinming Su, Zhiqing Zhan, Shuhan Zhou et autres

cn (code pays fourni par la source)

Dynamic interface printing: An innovative acoustically-driven 3D printing technology

Yuebing Zheng, Lichong Lu, Ling Zhu, Xinming Su et autres

cn (code pays fourni par la source)

miR-668: A versatile microRNA with disease-specific roles and therapeutic applications

Jiahua Si, Xinming Su, Jianqiao Shentu, Zehua Wang et autres

MicroRNAs (miRNAs) are endogenous single-stranded non-coding RNAs approximately 22 ​nt in length, which play a regulatory role in various biological processes by targeting and inhibiting protein-coding gene transcripts. Among the wide range of miRNAs, miR-668 exhibits abnormal expression patterns in different diseases, …

Supplementary Table S1 from p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

Douglas V. Faget, Xianmin Luo, Matthew J. Inkman, Qihao Ren et autres

Table containing all of our reagents

Supplementary Table S1 from p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

Douglas V. Faget, Xianmin Luo, Matthew J. Inkman, Qihao Ren et autres

Table containing all of our reagents